New Indications and Dosage Forms for 2004

See also: New Drug Approvals for 2004

January 13, 2004

AstraZeneca Receives FDA Approval for Seroquel for Treatment of Mania Associated with Bipolar Disorder

March 30, 2004

Zyprexa Eli Lilly - Treatment for Acute Agitation associated with Schizophrenia and Bipolar Mania

April 5, 2004

FDA Approves Biovail's Cardizem LA for the Treatment of Angina

April 7, 2004

FDA Approves Nasacort HFA for Allergic Rhinitis

September 7, 2004

FDA Approves Cymbalta for Neuropathic Pain Associated With Diabetes

October 18, 2004

Aricept ODT Eisai Inc. - Treatment for Alzheimer’s Disease

November 29, 2004

Nexium approved for reduced risk of stomach ulcer development among NSAID users

New indications and dosage forms archive

Recently Approved

Yesafili
Yesafili (aflibercept-jbvf) is a vascular endothelial growth factor (VEGF)...
Opuviz
Opuviz (aflibercept-yszy) is a vascular endothelial growth factor (VEGF)...
Imdelltra
Imdelltra (tarlatamab-dlle) is a first-in-class, bispecific delta-like ligand 3...

More drug approvals